
Keywords: Dengue; Vaccine; Tetravalent; Low-dose; Intradermal; LD-TDV; low-dose tetravalent dengue vaccine; AE; adverse event; DMID; Division of Microbiology and Infectious Diseases; SAE; serious adverse event; CPK; creatine phosphokinase; ALT; alanine transaminase